Live Breaking News & Updates on Ivs 3001|Page 1

Stay updated with breaking news from Ivs 3001. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Grants Fast Track Designation to IVS-3001 for Renal Cell Carcinoma

The FDA has granted fast track designation IVS-3001 for use as a potential therapeutic option in patients with renal cell carcinoma. ....

United States , Samer Srour , Jake Kushner , Maung Naing , Invectys Inc , University Of Texas Md Anderson Cancer Center , Cancer Center , Investigational Cancer Therapeutics , Stem Cell Transplantation , Cellular Therapy , Ivs 3001 , Patients With Renal Cell Carcinoma , The University Of Texas Md Anderson Cancer Center ,